Faculty profile

Nadia Giannetti

ResearcherMedicine/CardiologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Nadia Giannetti

Researcher

Medicine/Cardiology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
25 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

6,166

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardia Magnetic Resonnance Cardiovascular Outcomes Clinical Clustering Integrative Multi-Omics Latent Class Analysis Metabolomics/Lipidomics Molecular Phenotyping Precision Medicine

Latest papers

Evaluating and comparing the signalling and functional landscape of hiPSC-CMs derived from patients with dilated cardiomyopathy.
npj biomedical innovations · 2026
Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.
Heart failure reviews · 2026
Mechanosensing by T cells promotes a tissue-resident memory transcriptional program.
Nature immunology · 2026

All 71 publications

Latest funding

Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program
CIHR · 2025 · Principal investigator
$703,800
From the heart: Canadian women's lived experiences of heart failure
CIHR · 2020 · Co-investigator
$355,725
Geriatric Intervention for Frail Heart Failure patients: The GIF-HF Trial
CIHR · 2019 · Co-investigator
$428,400

All 3 grants and awards

71 publications.

Evaluating and comparing the signalling and functional landscape of hiPSC-CMs derived from patients with dilated cardiomyopathy.

Castagnola G, Loggia D, Bourque K, Alim K, Derish I, Rody E, Gryz Z, Hawey C, Jones-Tabah J, Bhardwaj A, Mouttet L, Gendron N, Giannetti N, Cecere R, Hui SK, Hébert TE

npj biomedical innovations2026

DOI: 10.1038/s44385-026-00111-8 PMID: 42728314

Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.

Haichin K, Leroux J, Giannetti N, Sharma A

Heart failure reviews2026

DOI: 10.1007/s10741-026-10662-y PMID: 42550328

Mechanosensing by T cells promotes a tissue-resident memory transcriptional program.

Postat J, Merino M, Mingarelli AR, Cerf A, Bhagrath A, Patel D, Shen C, Brodbeck J, Tirgar P, Rogers D, Blanc J, Jeyakumar T, Schneider C, Coley S, Giannetti N, DePauw TA, Textor J, Ehrlicher A, Jameson SC, Sharif-Naeini R, Sharma A, Mandl JN

Nature immunology2026

DOI: 10.1038/s41590-026-02581-9 PMID: 42399696

Personalizing the approach for the diagnosis of patients with concomitant Chronic Obstructive Pulmonary Disease and Heart failure.

Abou-Rjeili M, Farias R, Mostafavi Y, Smith B, Giannetti N, Bourbeau J

Respiratory medicine2026

DOI: 10.1016/j.rmed.2025.108628 PMID: 41478578

Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”

Panel: P, Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N

Canadian Journal of Cardiology20261 citations

DOI: 10.1016/j.cjca.2026.03.026

Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology2026

DOI: 10.1016/j.cjca.2025.12.030

Iatrogenic Traumatic Regional Pericarditis Secondary to Chest Tube Placement: A Case Report.

Ji DY, Prosty CJ, Garbis K, Giannetti N

CJC open2025Senior author

DOI: 10.1016/j.cjco.2025.04.001 PMID: 40586022

Transcending Age Barriers: Successful Management of Pediatric Dilated Cardiomyopathy with Rare PLEKHM2 Mutation in an Adult Hospital.

Bendayan S, Ganni E, Ordonez MV, Bendayan E, Cohen Y, Samoukovic G, Giannetti N

JACC. Case reports2025Senior author

DOI: 10.1016/j.jaccas.2024.103023 PMID: 40054934

Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology202523 citations

DOI: 10.1016/j.cjca.2025.07.027

Predictive Models Aid Prognostication Secondary Analysis Integrating Model and Physician Prognostic Estimates in Heart Failure

Alba AC, Buchan TA, Mueller B, Poon S, Mak S, Al-Hesayen A, Toma M, Zieroth S, Anderson K, Demers C

JACC: Advances20251 citations

DOI: 10.1016/j.jacadv.2025.102281

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Cardia Magnetic Resonnance Dear Professor Giannetti, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Evaluating and comparing the signalling and functional landscape of hiPSC-CMs derived from patients with dilated cardiomyopathy." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Nadia Giannetti

Research

Latest papers

Latest funding

Evaluating and comparing the signalling and functional landscape of hiPSC-CMs derived from patients with dilated cardiomyopathy.

Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.

Mechanosensing by T cells promotes a tissue-resident memory transcriptional program.

Personalizing the approach for the diagnosis of patients with concomitant Chronic Obstructive Pulmonary Disease and Heart failure.

Iatrogenic Traumatic Regional Pericarditis Secondary to Chest Tube Placement: A Case Report.

Transcending Age Barriers: Successful Management of Pediatric Dilated Cardiomyopathy with Rare PLEKHM2 Mutation in an Adult Hospital.

Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

Predictive Models Aid Prognostication Secondary Analysis Integrating Model and Physician Prognostic Estimates in Heart Failure

Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program

From the heart: Canadian women's lived experiences of heart failure

Geriatric Intervention for Frail Heart Failure patients: The GIF-HF Trial

Frequent collaborators

Abhinav Sharma

Subodh Verma

Lisa Mielniczuk

Douglas Lee

Robert McKelvie

Karen Harkness

Adam Grzeslo

Thao Huynh

Louise Pilote

Louise Pilote

Harriette Van Spall

Sabina Keen

Amelia Yip

Howard Abrams

Alexandra King

Sharon Chih

Lee Green

Catherine Demers

Jonathan Afilalo

Gordon Guyatt

Jonathan Afilalo

Michael Tsoukas

Robert Avram

Anne Dipchand